Abstract
Recently, technologies in designing novel drug delivery strategies have evolved to overcome challenges like biological barriers. Nanobiomaterials have shown significant potential as efficient drug carriers due to their variable sizes and characteristics. Additionally, nanobiomaterials have been applied in other fields of medicine, such as molecular imaging, detection of disease markers, vaccine development, and treatment of many body organs, such as the skin and nervous system. Nanobiomaterials are composed of different classes with unique properties that allow for more targeted and comprehensive performance at different sites. Nanoparticles are classified based on their structures and have been utilized in drug delivery systems to treat various disorders. Herein, the threats of applying these materials as drug carriers and the future of nanomaterials in medicine have been described. Our research has gone beyond explaining the potentials of highly applied nanoparticles used in drug delivery systems and has attempted to give insights about what measurements and modifications must be done in the case of nanobiomaterials to bring this multifaceted science into widespread utilization.
Similar content being viewed by others
Abbreviations
- GNPs:
-
Gold nanoparticles
- PAMAM:
-
Neutral hydroxyl-terminated polyamidoamine
- PM:
-
Polymeric micelles
- CRC:
-
Critical micelle concentration
- QD:
-
Quantum dots
- ECM:
-
Extracellular matrix
- MSC:
-
Mesenchymal stem cells
References
Abd Elkodous M, Olojede SO, Morsi M, El-Sayyad GS (2021) Nanomaterial-based drug delivery systems as promising carriers for patients with COVID-19. RSC Adv 11(43):26463–26480. https://doi.org/10.1039/D1RA04835J
Ahsan SM, Thomas M, Reddy KK, Sooraparaju SG, Asthana A, Bhatnagar I (2018) Chitosan as biomaterial in drug delivery and tissue engineering. Int J Biol Macromol 110:97–109. https://doi.org/10.1016/j.ijbiomac.2017.08.140
Almeida B, Nag OK, Rogers KE, Delehanty JB (2020) Recent progress in bioconjugation strategies for liposome-mediated drug delivery. Molecules (Basel, Switzerland) 25(23):5672. https://doi.org/10.3390/molecules25235672
Altavilla C, Ciliberto E (2011) Inorganic nanoparticles: synthesis, applications, and perspectives. CRC Press, Boca Raton, FL
Babaie S, Bakhshayesh ARD, Ha JW, Hamishehkar H, Kim KH (2020) Invasome: a novel nanocarrier for transdermal drug delivery. Nanomaterials (Basel, Switzerland) 10(2):341. https://doi.org/10.3390/nano10020341
Badıllı U, Mollarasouli F, Bakirhan NK, Ozkan Y, Ozkan SA (2020) Role of quantum dots in pharmaceutical and biomedical analysis, and its application in drug delivery. TrAC Trends in Anal Chem 131:116013. https://doi.org/10.1016/j.trac.2020.116013
Bakhshandeh B, Ranjbar N, Abbasi A et al (2023) Recent progress in the manipulation of biochemical and biophysical cues for engineering functional tissues. Bioeng Transl Med 8(2):e10383. https://doi.org/10.1002/btm2.10383
Bakhshandeh B, Soleimani M, Ghaemi N, Shabani I (2011) Effective combination of aligned nanocomposite nanofibers and human unrestricted somatic stem cells for bone tissue engineering. Acta Pharmacol Sin 32(5):626–636
Bakhshandeh B, Soleimani M, Hafizi M, Ghaemi N (2012) A comparative study on nonviral genetic modifications in cord blood and bone marrow mesenchymal stem cells. Cytotechnology 64(5):523–540
Bakhshandeh B, Sorboni SG, Haghighi DM, Ahmadi F, Dehghani Z, Badiei A (2022) New analytical methods using carbon-based nanomaterials for detection of Salmonella species as a major food poisoning organism in water and soil resources. Chemosphere 287:132243
Bakhshandeh B, Zarrintaj P, Oftadeh MO, Keramati F, Fouladiha H, Sohrabi-Jahromi S, Ziraksaz Z (2017) Tissue engineering; strategies, tissues, and biomaterials. Biotechnol Genet Eng Rev 33(2):144–172
Cevc G (1996) Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst 13(3–4):257–388. https://doi.org/10.1615/critrevtherdrugcarriersyst.v13.i3-4.30
Cheng A, Schwartz Z, Kahn A, Li X, Shao Z, Sun M, Chen H (2019) Advances in porous scaffold design for bone and cartilage tissue engineering and regeneration. Tissue Eng Part B Rev 25(1):14–29. https://doi.org/10.1089/ten.TEB.2018.0119
Chowdhury NK, Deepika, Choudhury R, Sonawane GA, Mavinamar S, Lyu X, Chang CM (2021) Nanoparticles as an effective drug delivery system in COVID-19. Biomed Pharmacother 143:112162. https://doi.org/10.1016/j.biopha.2021.112162
Chu PK, Liu X (2008) Biomaterials fabrication and processing handbook. CRC Press/Taylor & Francis, Boca Raton
Deng Y, Zhang X, Shen H, He Q, Wu Z, Liao W, Yuan M (2020) Application of the nano-drug delivery system in treatment of cardiovascular diseases. Front Bioeng Biotechnol 7:489–489. https://doi.org/10.3389/fbioe.2019.00489
Douroumis D, Fahr A (2012) Drug delivery strategies for poorly water-soluble drugs. John Wiley & Sons, Chichester, West Sussex
Ds A, Mj S (2016) Nanotechnology: the risks and benefits for medical diagnosis and treatment. J Nanomed Nanotechnol. https://doi.org/10.4172/2157-7439.1000e143
Fanun M (2010) Colloids in drug delivery. CRC Press/Taylor & Francis, Boca Raton, FL
Ge X, Wei M, He S, Yuan W-E (2019) Advances of non-ionic surfactant vesicles (Niosomes) and their application in drug delivery. Pharmaceutics 11(2):55. https://doi.org/10.3390/pharmaceutics11020055
Gelain F (2008) Novel opportunities and challenges offered by nanobiomaterials in tissue engineering. Int J Nanomed 3(4):415–424
Goldberg M, Langer R, Jia X (2007) Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed 18(3):241–268. https://doi.org/10.1163/156856207779996931
Gong J, Chen M, Zheng Y, Wang S, Wang Y (2012) Polymeric micelles drug delivery system in oncology. J Control Release 159(3):312–323. https://doi.org/10.1016/j.jconrel.2011.12.012
Gonsalves KE (2008) Biomedical nanostructures. Wiley-Interscience, Hoboken, NJ
Gu J, Hu W, Song Z-P, Chen Y-G, Zhang D-D, Wang C-Q (2016) Rapamycin inhibits cardiac hypertrophy by promoting autophagy via the MEK/ERK/Beclin-1 pathway. Front Phys. https://doi.org/10.3389/fphys.2016.00104
Hauser M, Li G, Nowack B (2019) Environmental hazard assessment for polymeric and inorganic nanobiomaterials used in drug delivery. J Nanobiotechnol 17(1):56–56. https://doi.org/10.1186/s12951-019-0489-8
Helary C, Desimone MF (2015) Recent advances in biomaterials for tissue engineering and controlled drug delivery. Curr Pharm Biotechnol 16(7):635–645. https://doi.org/10.2174/138920101607150427112208
Holzapfel BM, Rudert M, Hutmacher DW (2017) Scaffold-based bone tissue engineering. Orthopade 46(8):701–710. https://doi.org/10.1007/s00132-017-3444-0
Hurst SJ (2011) Biomedical nanotechnology: methods and protocols. Humana Press, New York
Jackson CB, Farzan M, Chen B, Choe H (2022) Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol 23(1):3–20. https://doi.org/10.1038/s41580-021-00418-x
Jahanafrooz Z, Bakhshandeh B, Shirzadi E (2023) Comparative evaluation of lipofectamine and dendrimer for transfection of short RNA into human T47D and MCF-10A cell lines. Adv Pharm Bull 13(2):385–392. https://doi.org/10.34172/apb.2023.022
Jahanafrooz Z, Motamed N, Bakhshandeh B (2017) Effects of miR-21 downregulation and silibinin treatment in breast cancer cell lines. Cytotechnology 69(4):667–680. https://doi.org/10.1007/s10616-017-0076-5
Jain S, Jain V, Mahajan SC (2014) Lipid based vesicular drug delivery systems. Adv Pharm 2014:574673. https://doi.org/10.1155/2014/574673
Jesus S, Schmutz M, Som C, Borchard G, Wick P, Borges O (2019) Hazard assessment of polymeric nanobiomaterials for drug delivery: What can we learn from literature so far. Front Bioeng Biotechnol 7:261–261. https://doi.org/10.3389/fbioe.2019.00261
Jhaveri AM, Torchilin VP (2014) Multifunctional polymeric micelles for delivery of drugs and siRNA. Front Pharmacol 5:77. https://doi.org/10.3389/fphar.2014.00077
Joseph X, Akhil V, Arathi A, Mohanan PV (2022) Nanobiomaterials in support of drug delivery related issues. Mater Sci Eng B 279:115680. https://doi.org/10.1016/j.mseb.2022.115680
Kanazawa T, Sugawara K, Tanaka K, Horiuchi S, Takashima Y, Okada H (2012) Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG–PCL nanomicelles. Eur J Pharm Biopharm 81(3):470–477. https://doi.org/10.1016/j.ejpb.2012.04.021
Karthivashan G, Ganesan P, Park SY, Kim JS, Choi DK (2018) Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease. Drug Deliv 25(1):307–320. https://doi.org/10.1080/10717544.2018.1428243
Kazi KM, Mandal AS, Biswas N, Guha A, Chatterjee S, Behera M, Kuotsu K (2010) Niosome: a future of targeted drug delivery systems. J Adv Pharm Technol Res 1(4):374–380. https://doi.org/10.4103/0110-5558.76435
Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Wan Kim S, Seo MH (2001) In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release 72(1–3):191–202. https://doi.org/10.1016/s0168-3659(01)00275-9
Kumar SSD, Abrahamse H (2020) Advancement of nanobiomaterials to deliver natural compounds for tissue engineering applications. Int J Mol Sci 21(18):6752
Lakshmanan R, Maulik N (2018) Graphene-based drug delivery systems in tissue engineering and nanomedicine. Can J Physiol Pharmacol 96(9):869–878. https://doi.org/10.1139/cjpp-2018-0225
Lee JW, Foote RS (2009) Micro and nano technologies in bioanalysis: methods and protocols. Humana Press, Dordrecht, New York
Li Z, Tan S, Li S, Shen Q, Wang K (2017) Cancer drug delivery in the nano era: an overview and perspectives (Review). Oncol Rep 38(2):611–624. https://doi.org/10.3892/or.2017.5718
Lungu II, Grumezescu AM, Volceanov A, Andronescu E (2019) Nanobiomaterials used in cancer therapy: an up-to-date overview. Molecules (Basel, Switzerland) 24(19):3547. https://doi.org/10.3390/molecules24193547
Ma Q, Cao J, Gao Y, Han S, Liang Y, Zhang T, Sun Y (2020) Microfluidic-mediated nano-drug delivery systems: from fundamentals to fabrication for advanced therapeutic applications. Nanoscale 12(29):15512–15527. https://doi.org/10.1039/D0NR02397C
Madaan K, Kumar S, Poonia N, Lather V, Pandita D (2014) Dendrimers in drug delivery and targeting: drug-dendrimer interactions and toxicity issues. J Pharm Bioallied Sci 6(3):139–150. https://doi.org/10.4103/0975-7406.130965
Maeki M, Kimura N, Sato Y, Harashima H, Tokeshi M (2018) Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems. Adv Drug Deliv Rev 128:84–100. https://doi.org/10.1016/j.addr.2018.03.008
Matea CT, Mocan T, Tabaran F, Pop T, Mosteanu O, Puia C, Mocan L (2017) Quantum dots in imaging, drug delivery and sensor applications. Int J Nanomed 12:5421–5431. https://doi.org/10.2147/IJN.S138624
Melchor-Martínez EM, Torres Castillo NE, Macias-Garbett R, Lucero-Saucedo SL, Parra-Saldívar R, Sosa-Hernández JE (2021) Modern world applications for nano-bio materials: tissue engineering and COVID-19. Front Bioeng Biotechnol. https://doi.org/10.3389/fbioe.2021.597958
Mikušová V, Mikuš P (2021) Advances in chitosan-based nanoparticles for drug delivery. Int J Mol Sci 22(17):9652
Opatha SAT, Titapiwatanakun V, Chutoprapat R (2020) Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics 12(9):855. https://doi.org/10.3390/pharmaceutics12090855
Park K (2013) Biomaterials for cancer therapeutics: diagnosis, prevention and therapy. Woodhead Publishing, Oxford
Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, Shin H-S (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 16(1):71–71. https://doi.org/10.1186/s12951-018-0392-8
Probst CE, Zrazhevskiy P, Bagalkot V, Gao X (2013) Quantum dots as a platform for nanoparticle drug delivery vehicle design. Adv Drug Deliv Rev 65(5):703–718. https://doi.org/10.1016/j.addr.2012.09.036
Puttappa N, Kumar RS, Kuppusamy G, Radhakrishnan A (2019) Nano-facilitated drug delivery strategies in the treatment of plasmodium infection. Acta Trop 195:103–114. https://doi.org/10.1016/j.actatropica.2019.04.020
Rana D, Ramasamy K, Leena M, Jiménez C, Campos J, Ibarra P, Ramalingam M (2016) Surface functionalization of nanobiomaterials for application in stem cell culture, tissue engineering, and regenerative medicine. Biotechnol Prog 32(3):554–567. https://doi.org/10.1002/btpr.2262
Rolley N, Bonnin M, Lefebvre G, Verron S, Bargiel S, Robert L, Calvignac B (2021) Galenic lab-on-a-chip concept for lipid nanocapsules production. Nanoscale 13(27):11899–11912. https://doi.org/10.1039/D1NR00879J
Sapkota R, Dash AK (2021) Liposomes and transferosomes: a breakthrough in topical and transdermal delivery. Ther Deliv 12(2):145–158. https://doi.org/10.4155/tde-2020-0122
Sharma A, Liaw K, Sharma R, Zhang Z, Kannan S, Kannan RM (2018) Targeting mitochondrial dysfunction and oxidative stress in activated microglia using dendrimer-based therapeutics. Theranostics 8(20):5529–5547. https://doi.org/10.7150/thno.29039
Sharma AK, Keservani RK (2019) Dendrimers for drug delivery. Apple Academic Press, Oakville, Waretown
Shukla A, Mishra V, Kesharwani P (2016) Bilosomes in the context of oral immunization: development, challenges and opportunities. Drug Discovery Today 21(6):888–899. https://doi.org/10.1016/j.drudis.2016.03.013
Silva Adaya D, Aguirre-Cruz L, Guevara J, Ortiz-Islas E (2017) Nanobiomaterials’ applications in neurodegenerative diseases. J Biomater Appl 31(7):953–984. https://doi.org/10.1177/0885328216659032
Soloviev M (2012) Nanoparticles in biology and medicine: methods and protocols. Humana Press/Springer, New York
Verma P, Pathak K (2010) Therapeutic and cosmeceutical potential of ethosomes: an overview. J Adv Pharm Technol Res 1(3):274–282. https://doi.org/10.4103/0110-5558.72415
Virlan MJR, Miricescu D, Radulescu R, Sabliov CM, Totan A, Calenic B, Greabu M (2016) Organic nanomaterials and their applications in the treatment of oral diseases. Molecules (Basel, Switzerland) 21(2):207. https://doi.org/10.3390/molecules21020207
Wang W, Lu K-J, Yu C-H, Huang Q-L, Du Y-Z (2019) Nano-drug delivery systems in wound treatment and skin regeneration. J Nanobiotechnol 17(1):82–82. https://doi.org/10.1186/s12951-019-0514-y
Wilczewska AZ, Niemirowicz K, Markiewicz KH, Car H (2012) Nanoparticles as drug delivery systems. Pharmacol Rep 64(5):1020–1037. https://doi.org/10.1016/s1734-1140(12)70901-5
Zarrintaj P, Bakhshandeh B, Saeb MR, Sefat F, Rezaeian I, Ganjali MR, Mozafari M (2018) Oligoaniline-based conductive biomaterials for tissue engineering. Acta Biomater 72:16–34. https://doi.org/10.1016/j.actbio.2018.03.042
Zeineldin R (2017) Cancer nanotechnology: methods and protocols. Humana Press, New York
Ziraksaz Z, Nomani A, Soleimani M, Bakhshandeh B, Arefian E, Haririan I, Tabbakhian M (2013) Evaluation of cationic dendrimer and lipid as transfection reagents of short RNAs for stem cell modification. Int J Pharm 448(1):231–238. https://doi.org/10.1016/j.ijpharm.2013.03.035
Funding
The authors received no specific funding for this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kazemi, N., Bakhshandeh, B., Dehghani, Z. et al. Nanobiomaterials in drug delivery: from science to applications. Polym. Bull. 81, 5823–5838 (2024). https://doi.org/10.1007/s00289-023-05006-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00289-023-05006-x